Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5191 AL 5205

Clinical diagnosis in preclinical stage of Alzheimer's disease

Fuentes P.

Arch Med Res. 2012 Nov;43(8):667-70. doi: 10.1016/j.arcmed.2012.10.014. Epub 2012 Nov 3.

Emerging noninvasive biomarkers for early detection of Alzheimer's disease

Guzmán-Martínez L, Farías GA, Maccioni RB.

Arch Med Res. 2012 Nov;43(8):663-6. doi: 10.1016/j.arcmed.2012.10.013. Epub 2012 Nov 7.

Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia

Román G, Pascual B.

Arch Med Res. 2012 Nov;43(8):671-6. doi: 10.1016/j.arcmed.2012.10.018. Epub 2012 Nov 8.

Finding a pathological diagnosis for Alzheimer's disease: are inflammatory molecules the answer?

Bhamra MS, Ashton NJ.

Electrophoresis. 2012 Dec;33(24):3598-607. doi: 10.1002/elps.201200161. Epub 2012 Nov 26.

Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder

Jakobsson J, Zetterberg H, Blennow K, Johan Ekman C, Johansson AG, Landén M.

Neuropsychopharmacology. 2013 Mar;38(4):664-72. doi: 10.1038/npp.2012.231. Epub 2012 Nov 6.

mCiRNA-synaptic crystal ball?

Bredesen D.

Aging (Albany NY). 2012 Nov;4(11):732-3. doi: 10.18632/aging.100511.

Research and standardization in Alzheimer's trials: reaching international consensus

Carrillo MC, Rowe CC, Szoeke C, Masters CL, Ames D, O'Meara T, Macaulay SL, Milner A, Ellis KA, Maruff P, Rainey-Smith SR, Martins RN, Bain LJ, Head RJ; NIA/Alzheimer Association and International Working Group.

Alzheimers Dement. 2013 Mar;9(2):160-8. doi: 10.1016/j.jalz.2012.10.006. Epub 2012 Dec 23.

[Early evaluation of Alzheimer's disease: biomarkers and neuropsychological tests]

Lanfranco RG, Manríquez-Navarro P, Avello LG, Canales-Johnson A.

Rev Med Chil. 2012 Sep;140(9):1191-200. doi: 10.4067/S0034-98872012000900014.

[Exploring the early diagnostic biomarkers for Alzheimer's disease]

Yamasaki T, Tobimatsu S.

Fukuoka Igaku Zasshi. 2012 Nov;103(11):215-25.

[Alzheimer disease and other dementia in France: Identification, management and neuroleptic use (2007-2009)]

Tuppin P, Cuerq A, Weill A, Ricordeau P, Allemand H.

Rev Neurol (Paris). 2012 Feb;168(2):152-60. doi: 10.1016/j.neurol.2011.08.011. Epub 2011 Nov 21.

Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment

Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, Zanca M, Portet F, Touchon J, Verny M, Mahieux F, Giron A, Fertil B, Dubois B.

Neurobiol Aging. 2011 Jan;32(1):15-23. doi: 10.1016/j.neurobiolaging.2009.01.013. Epub 2009 Feb 27.

Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study

Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium.

Neurobiol Aging. 2011 Jul;32(7):1198-206. doi: 10.1016/j.neurobiolaging.2009.07.008. Epub 2009 Aug 14.

Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment

Molinuevo JL, Berthier ML, Rami L.

Arch Gerontol Geriatr. 2011 Jan-Feb;52(1):18-22. doi: 10.1016/j.archger.2009.11.004. Epub 2009 Nov 30.

Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies

Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV.

Neurobiol Aging. 2011 Oct;32(10):1733-41. doi: 10.1016/j.neurobiolaging.2009.11.008. Epub 2009 Dec 11.

Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease

Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J.

Int J Geriatr Psychiatry. 2011 Feb;26(2):150-7. doi: 10.1002/gps.2507.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias